Sign in Subscribe

Provider Reform

Reforms to service pricing and reimbursement across hospital and retail settings—shaping how innovative medicines are adopted and accessed through key distribution channels in China.
Dec
04
NHSA Strengthens Control Over Outpatient Spending

NHSA Strengthens Control Over Outpatient Spending

Effectively navigating these regulatory changes will have significant and lasting implications for drug manufacturers, particularly in shaping their pricing strategies, reimbursement models, and distribution channel approaches in China.
7 min read
Nov
06
Advances in New Technology Add-On Payments for Innovative Medicine in China’s DRG/DIP Framework

Advances in New Technology Add-On Payments for Innovative Medicine in China’s DRG/DIP Framework

In July, China’s National Healthcare Security Administration introduced the CHS-DRG Grouping Plan (Version 2.0), expanding the number of
5 min read
Oct
15
▶️China's Medical Service Pricing Reform: Impact on Innovative Medical Technology Pricing and Adoption

▶️China's Medical Service Pricing Reform: Impact on Innovative Medical Technology Pricing and Adoption

Stay ahead of value-based approval and pricing trends for medical services and discover strategic growth opportunities to support clinical and commercial strategies for innovative medical technologies in China.
1 min read
Oct
02
Capitalizing on Specialized Medical Services in China: Opportunities for Innovative Life Sciences Manufacturers

Capitalizing on Specialized Medical Services in China: Opportunities for Innovative Life Sciences Manufacturers

To take advantage of these opportunities, manufacturers must focus on three key success factors.
6 min read
Aug
28
Three Key Trends Shaping Pricing for Innovative Non-VBP Medical Devices in China

Three Key Trends Shaping Pricing for Innovative Non-VBP Medical Devices in China

Understanding and strategically applying these trends is crucial for optimizing pricing strategies and enhancing market adoption of innovative medical technologies in China.
7 min read
Jul
10
5 Trillion-Yuan Equipment Renewal and China's National Quota System for Large Medical Equipment

5 Trillion-Yuan Equipment Renewal and China's National Quota System for Large Medical Equipment

In China, large medical equipment is managed through a planned allocation and permit system. Medical institutions must follow specific plans, meet clinical and functional requirements, and have the necessary technical infrastructure and qualified staff.
4 min read
Jul
03
NHSA Quietly Releases Implementation Guides for Establishing Medical Service Pricing Items

NHSA Quietly Releases Implementation Guides for Establishing Medical Service Pricing Items

Executive Summary In China, both public and private not-for-profit hospitals are required to adhere to the Medical Service Pricing Catalogs
5 min read
Jun
19
Shanghai Pilots: Leading Value-Based and Risk-Sharing Reimbursement for Medical Consumables in China

Shanghai Pilots: Leading Value-Based and Risk-Sharing Reimbursement for Medical Consumables in China

Shanghai utilizes value-based pricing negotiations and performance-linked payments for medical consumable reimbursements, providing insights into the future direction of high-value medical consumable reimbursement under China's basic medical insurance.
7 min read
Feb
14
China's DRG/DIP Reform: Bridging Medical Service Pricing and Supporting Tech Innovation

China's DRG/DIP Reform: Bridging Medical Service Pricing and Supporting Tech Innovation

The DRG/DIP payment reform has curtailed the rapid expansion of China's public hospitals, shifting focus to quality
5 min read
Nov
22
China's Medical Service Pricing Reform: Current State and Future Development

China's Medical Service Pricing Reform: Current State and Future Development

In our last newsletter, we delved into the three fundamental issues connected with medical service pricing in China: * Fragmented pricing
7 min read